SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing extreme downward pressure after federal indictments revealed a co-founder and other executives were involved in a massive chip smuggling scheme to China. Investors are reeling from the news, with widespread community discussion focused on concerns over potential delisting, loss of institutional trust, and fears that major partners may distance themselves from the company.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is facing intense market volatility and negative investor sentiment as the community debates the broader economic fallout of the escalating conflict in the Middle East. Discussion is heavily focused on the company's declining valuation, concerns over potential share dilution, and the polarizing political discourse surrounding the administration's foreign policy and economic management.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense downward pressure driven by a combination of broader market volatility, concerns over its high valuation, and persistent skepticism regarding its autonomous driving timeline. Investors and community members are actively debating the stock's support levels, with many expressing frustration over the lack of price stabilization while others look for accumulation opportunities amidst the ongoing sell-off.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Market participants are bracing for volatility as geopolitical tensions in the Middle East, specifically involving Iran and potential ground operations, fuel fears of an energy shock and broader economic instability. The community is actively debating the impact of these developments on market liquidity and the effectiveness of current policy, with many traders closely monitoring support levels while others speculate on potential weekend updates from leadership.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is seeing intense volatility and speculative interest as traders attempt to play the company as a tactical hedge against the escalating energy crisis in Europe. The community is heavily polarized between bullish holders betting on long-term supply demand and short-term traders debating whether the stock is a legitimate infrastructure play or a high-risk momentum trap.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is currently trending as investors focus on the company's recent 'substantial compliance' milestone from NOAA, which analysts view as a pivotal step toward securing commercial deep-sea mining permits. Community discussion is dominated by bullish sentiment regarding the company's strategic value for U.S. mineral independence, high-volume options activity, and anticipation surrounding upcoming earnings and the spin-off of TMCR.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp. is seeing intense volatility as the community debates the impact of potential geopolitical conflicts on the supply of critical minerals and the company's upcoming earnings report. While some investors express bullish sentiment over the company's defense-adjacent contracts and strategic resource acquisitions, others are actively trading based on perceived manipulation, dark pool activity, and speculative short-term price swings.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Market sentiment remains heavily bearish as the Nasdaq 100 faces intense pressure from geopolitical instability in the Strait of Hormuz and concerns over rising inflation, leading investors to offload tech-heavy positions amid a broader market correction. The community is actively debating the impact of upcoming ground operations in Iran, while many traders express frustration over aggressive price swings and ongoing volatility during this triple witching expiration.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as investors weigh significant government backing and defense-sector demand against volatile price action and ongoing concerns regarding a conflict of interest in its major deal with the U.S. government. Community discussion remains heavily polarized, with many retail investors aggressively buying the dip on the belief that rare-earth supply chain independence will trigger a massive squeeze, while others warn of potential downward pressure and regulatory risks.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

The Defiance Daily Target 2X Long SMCI ETF (SMCX) is currently experiencing extreme volatility and intense community frustration following a severe price drop tied to an investigation into its underlying asset. Investors are actively debating whether to treat the sharp decline as a buying opportunity or a terminal 'death trap,' with many expressing deep concern over the fund's mechanics, potential for further reverse splits, and the broader risks of holding leveraged products during a major corporate scandal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus

ALLO, SBUX and AMGN highlight how Zacks strategies and portfolio picks are delivering strong gains despite recent market volatility.

Intellia Therapeutics (NASDAQ:NTLA) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Intellia Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of "Hold" by Brokerages

Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Get Free Report) have received an average recommendation of "Hold" from the twenty-one analysts that are presently covering the stock, Marketbeat...

ARK Investment Management LLC Trims Stake in Intellia Therapeutics, Inc. $NTLA

ARK Investment Management LLC lessened its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 8.4% in the third quarter, according to the company in its most recent filing with...

Intellia Therapeutics (NASDAQ:NTLA) Upgraded at JonesTrading

JonesTrading raised Intellia Therapeutics from a "hold" rating to a "buy" rating and set a $29.00 price objective for the company in a research report on Wednesday...

Intellia Therapeutics (NASDAQ:NTLA) Given New $48.00 Price Target at Canaccord Genuity Group

Canaccord Genuity Group cut their price objective on shares of Intellia Therapeutics from $54.00 to $48.00 and set a "buy" rating on the stock in a research report on Tuesday...

Leerink Partners Issues Positive Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock Price

Leerink Partners lifted their price target on shares of Intellia Therapeutics from $27.00 to $29.00 and gave the company an "outperform" rating in a research note on Tuesday...

Royal Bank Of Canada Issues Positive Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock Price

Royal Bank Of Canada lifted their price target on shares of Intellia Therapeutics from $9.00 to $15.00 and gave the company a "sector perform" rating in a research report on Tuesday...

Wells Fargo & Company Issues Positive Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock Price

Wells Fargo & Company increased their target price on Intellia Therapeutics from $12.00 to $15.00 and gave the stock an "equal weight" rating in a research report on Tuesday...

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Key PointsArk Invest bought shares of MercadoLibre, Intellia Therapeutics, and Generate Biomedicines on Monday...

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

NTLA
Intellia Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NTLA News

NTLAIntellia Therapeutics Inc